Reactive oxygen species and PI3K/Akt signaling in cancer

Seo Yeon Jin1, Hye Sun Lee2, Eun Kyoung Kim2

  • 1College of Medicine, Pusan National University (Busan National Univ. Yangsan campus, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do, Korea), Department of Pharmacology, Republic of Korea..

Insights

Insulin-like growth factor-1 (IGF-1) triggers reactive oxygen species (ROS) in ovarian cancer cells. This process involves the PI3K/Akt/mTOR2/NADPH oxidase pathway, crucial for cell migration and ROS generation.

Area of Science:

  • Cell Biology
  • Oncology
  • Biochemistry

Background:

  • Reactive oxygen species (ROS) are vital in cellular functions like proliferation and apoptosis.
  • Insulin-like growth factor-1 (IGF-1) plays a role in modulating ovarian cancer cell behavior.

Purpose of the Study:

  • To investigate the role of IGF-1 in regulating ROS generation in SKOV-3 ovarian cancer cells.
  • To elucidate the specific signaling pathways involved in IGF-1-induced ROS production.

Main Methods:

  • Utilized specific inhibitors for PI3K, Akt, ERK, and mTORC1.
  • Employed gene silencing techniques for Rictor, Raptor, Akt1, Akt2, and P-Rex1.
  • Assessed ROS generation and cell migration.
  • Investigated the involvement of the NADPH oxidase system.

Main Results:

  • IGF-1-induced ROS generation was blocked by PI3K and Akt inhibitors, but not by ERK or mTORC1 inhibitors.
  • Inactivation of mTORC2 (via Rictor silencing) abolished IGF-1-induced cell migration and Akt activation.
  • Akt1, but not Akt2, was essential for IGF-1-induced ROS generation.
  • P-Rex1 silencing and NADPH oxidase inhibition abrogated IGF-1-induced ROS production.

Conclusions:

  • IGF-1 stimulates ROS generation in ovarian cancer cells via the PI3K/Akt/mTOR2/NADPH oxidase signaling axis.
  • This pathway is critical for IGF-1-mediated SKOV-3 cell migration and ROS production.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K